NEURODERM LTD's ticker is and the CUSIP is M74231107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,284,000 | -73.7% | 57,825 | -78.1% | 0.09% | -71.1% |
| Q3 2016 | $4,883,000 | +11.3% | 264,114 | -2.2% | 0.32% | +3.6% |
| Q2 2016 | $4,388,000 | +15.1% | 270,000 | 0.0% | 0.30% | -9.0% |
| Q1 2016 | $3,812,000 | -17.2% | 270,000 | 0.0% | 0.33% | -2.1% |
| Q4 2015 | $4,604,000 | -58.8% | 270,000 | -50.0% | 0.34% | -23.5% |
| Q3 2015 | $11,162,000 | +263.6% | 540,000 | +170.0% | 0.45% | +141.1% |
| Q2 2015 | $3,070,000 | -34.6% | 200,000 | -42.9% | 0.18% | -49.3% |
| Q1 2015 | $4,697,000 | -4.4% | 350,000 | 0.0% | 0.36% | -11.4% |
| Q4 2014 | $4,914,000 | – | 350,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 261,945 | $4,466,000 | 3.96% |
| ACUTA CAPITAL PARTNERS, LLC | 477,300 | $8,138,000 | 3.89% |
| Avoro Capital Advisors LLC | 520,022 | $8,866,000 | 3.05% |
| Redmile Group, LLC | 1,589,261 | $27,097,000 | 2.03% |
| NEXTHERA CAPITAL LP | 48,000 | $818,000 | 1.16% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,749,038 | $46,871,000 | 0.93% |
| SENZAR ASSET MANAGEMENT, LLC | 201,700 | $3,438,985,000 | 0.38% |
| Perceptive Advisors | 270,000 | $4,604,000 | 0.34% |
| Foresite Capital Management II, LLC | 55,779 | $951,000 | 0.32% |
| RA Capital Management | 144,671 | $2,467,000 | 0.24% |